SEC Form 4 · accession 0001140361-18-021823
Unity Biotechnology, Inc. · UBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Nelsen
Director · 10% Owner
Period of report
May 2, 2018
Accepted (ET)
May 4, 2018 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001463361
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.00 | May 2, 2018 | A | 40,678 | A | — | May 1, 2028 | Common Stock | 40,678 | 40,678 | D |
Explanation of responses
- F1The shares underlying the option shall vest as to 1/3rd of the underlying shares on each anniversary of May 2, 2018, subject to the Non-Employee Director continuing to serve on the Board through such vesting date.